Study List


Study List

Clinical Studies

NCT Number Status Brief Title View
NCT00004941 Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody cA2 for Patients With Enterocutaneous Fistulae as a Complication of Crohns Disease View
NCT00004940 Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria View
NCT00004939 Phase III Randomized Double-Blind Placebo-Controlled Study of 34-Diaminopyridine for Demyelinating Polyneuropathy View
NCT00004938 Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis View
NCT00004937 Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme View
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients View
NCT00004935 Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 View
NCT00004934 Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB Stage III or Stage IV Invasive Ovarian Epithelial Fallopian Tube or Peritoneal Cancer View
NCT00004933 Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa View
NCT00004932 STI571 in Treating Patients With Recurrent Leukemia View
NCT00004931 Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer View
NCT00004930 Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases View
NCT00004929 Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer View
NCT00004928 Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer View
NCT00004927 BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy View
NCT00004926 ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy View
NCT00004925 Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced Inflammatory or Metastatic Breast Cancer View
NCT00004924 Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer View
NCT00004923 Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors View
NCT00004922 Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors View
NCT00004921 High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery View
NCT00004920 Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura View
NCT00004919 Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy View
NCT00004918 Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia Acute Myeloid Leukemia or Myelodysplastic Syndrome View
NCT00004917 Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer View
NCT00004916 Ifosfamide Teniposide and Paclitaxel in Treating Patients With Relapsed Non-Hodgkins Lymphoma View
NCT00004915 Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer View
NCT00004914 Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue View
NCT00004913 Combination Chemotherapy in Treating Patients With Advanced Solid Tumors View
NCT00004912 Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss View
NCT00004911 Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction View
NCT00004910 Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction View
NCT00004909 Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer View
NCT00004908 Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkins Disease or Non-Hodgkins Lymphoma View
NCT00004907 Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma Hodgkins Lymphoma or Non-Hodgkins Lymphoma View
NCT00004906 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer View
NCT00004905 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia View
NCT00004904 Stem Cell Transplantation in Treating Patients With Hematologic Cancer View
NCT00004903 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma View
NCT00004902 Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma View
NCT00004901 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer View
NCT00004900 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer View
NCT00004899 Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome View
NCT00004898 Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia View
NCT00004897 Combination Chemotherapy and Interferon Alfa Followed by Surgery andor Radiation Therapy in Treating Patients With Stage I Stage II or Stage III Esophageal Cancer View
NCT00004896 Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome View
NCT00004895 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery View
NCT00004893 Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer View
NCT00004892 O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma View
NCT00004891 PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery View
NCT00004890 Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer View
NCT00004889 Rituximab in Treating Patients With Waldenstroms Macroglobulinemia View
NCT00004888 Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer View
NCT00004887 Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery View
NCT00004886 MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors View
NCT00004885 Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer View
NCT00004884 Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer View
NCT00004883 Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 View
NCT00004881 Vaccine Therapy in Treating Patients With Advanced Cancer View
NCT00004880 Vaccine Therapy in Treating Patients With Advanced Kidney Cancer View
NCT00004879 Monoclonal Antibody ABX-EGF in Treating Patients With Renal Kidney Prostate Pancreatic Non-Small Cell Lung Colon or Rectal Esophageal or Gastroesophageal Junction Cancer View
NCT00004878 Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia View
NCT00004877 BMS-214662 in Treating Patients With Advanced Solid Tumors View
NCT00004876 Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer View
NCT00004875 Heparin or Enoxaparin in Patients With Cancer View
NCT00004874 Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkins Lymphoma View
NCT00004873 Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer View
NCT00004872 Endostatin in Treating Patients With Advanced Refractory Solid Tumors View
NCT00004871 Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome View
NCT00004870 Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer View
NCT00004868 SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy View
NCT00004867 Positron Emission Tomography in Determining Stage of Esophageal Cancer View
NCT00004866 DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix View
NCT00004865 Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy View
NCT00004864 Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors View
NCT00004863 Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors View
NCT00004862 Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia View
NCT00004861 Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer View
NCT00004860 Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer View
NCT00004859 Carboplatin Paclitaxel and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer View
NCT00004858 Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkins Lymphoma View
NCT00004857 Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia View
NCT00004856 Trastuzumab in Treating Patients With Previously Treated Locally Advanced or Metastatic Cancer of the Urothelium View
NCT00004855 Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs View
NCT00004854 The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure View
NCT00004853 Comparison of Filgrastim and Filgrastim SD01in Boosting White Cell Counts After Intensive Chemotherapy View
NCT00004852 Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs View
NCT00004851 Generation of Anti-HCV Antibodies From Bone Marrow Defining the Repertoire of Immune Response to HCV Quasispecies View
NCT00004850 Epidemiology Infectivity and Natural History of Hepatitis C Virus Infection View
NCT00004848 A Controlled Prospective Study of Transfusion-Associated Hepatitis View
NCT00004847 Diagnosis of Pheochromocytoma View
NCT00004846 Nucleic Acid Amplification Testing NAT of Blood Donors for HCV and HIV View
NCT00004845 A Multicenter Trial of Rofecoxib and Naproxen in Alzheimers Disease NSAID Study View
NCT00004844 Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinsons Disease View
NCT00004843 A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism View
NCT00004842 Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis View
NCT00004840 Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants View
NCT00004838 Randomized Study of Succimer Dimercaptosuccinic Acid on Growth of Lead-Poisoned Children View
NCT00004834 Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder View
NCT00004833 Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome View
NCT00004832 Randomized Study of 34-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome View
NCT00004831 Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria View
NCT00004829 Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis View
NCT00004828 Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure View
NCT00004827 Study of Docosahexaenoic Acid DHA Supplementation in Patients With X-Linked Retinitis Pigmentosa View
NCT00004826 Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinsons Disease View
NCT00004825 Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism View
NCT00004817 Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures View
NCT00004816 A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis View
NCT00004815 Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werners Syndrome View
NCT00004814 Phase III Randomized Double-Blind Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis View
NCT00004812 Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury View
NCT00004811 Phase III Study of Itraconazole for Blastomycosis Histoplasmosis and Sporotrichosis View
NCT00004810 Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis View
NCT00004809 Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia View
NCT00004808 Phase II Pilot Study of Fluconazole for Histoplasmosis Blastomycosis and Sporotrichosis View
NCT00004807 Study of the Pathogenesis of Rett Syndrome View
NCT00004806 Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis View
NCT00004805 Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death View
NCT00004804 Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C View
NCT00004802 Phase III Randomized Double-Blind Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders View
NCT00004801 Phase III Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency View
NCT00004800 Phase III Randomized Double-Blind Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines View
NCT00004799 Phase III Randomized Double-Blind Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines View
NCT00004797 Pilot Study of Fructose for Sickle Cell Crisis View
NCT00004796 Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis View
NCT00004795 Phase IIIII Randomized Double-Blind Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus View
NCT00004794 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis View
NCT00004793 Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children View
NCT00004791 Study of the Nutritional Metabolic and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa View
NCT00004789 Phase III Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria View
NCT00004788 Study of Nutritional Factors in Porphyria View
NCT00004787 Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes View
NCT00004786 Phase III Randomized Double-Blind Placebo-Controlled Study of Oral Iloprost for Raynauds Phenomenon Secondary to Systemic Sclerosis View
NCT00004785 Phase III Randomized Double-Blind Study of Dexamethasone Vs DexamethasoneMethylprednisolone Vs Placebo for Bronchopulmonary Dysplasia View
NCT00004784 Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis View
NCT00004781 Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups View
NCT00004779 Phase I Pilot Study of Ad5-CB-CFTR an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene in Patients With Cystic Fibrosis View
NCT00004778 Phase III Randomized Double-Blind Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery View
NCT00004776 Phase III Randomized Double-Blind Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome View
NCT00004773 Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome View
NCT00004772 Phase III Randomized Double-Blind Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy View
NCT00004771 Phase II Study of Leuprolide and Testosterone for Men With Kennedys Disease or Other Motor Neuron Disease View
NCT00004770 Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy View
NCT00004769 Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy View
NCT00004767 Phase II Study of Sodium Phenylbutyrate Sodium Benzoate Sodium Phenylacetate and Dietary Intervention for Urea Cycle Disorders View
NCT00004763 Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism View
NCT00004762 Phase II Pilot Study of Cladribine 2-Chlorodeoxyadenosine 2-CdA for Early Stage Primary Sclerosing Cholangitis View
NCT00004761 Establishment of the National Epidermolysis Bullosa Registry View
NCT00004760 Study of Axial Mobility Exercises in Parkinson Disease View
NCT00004759 Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury View
NCT00004758 Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment View
NCT00004757 Phase III Randomized Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin Eyes and Mouth View
NCT00004756 Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus View
NCT00004755 Allopurinol Glucantime or AllopurinolGlucantime for Cutaneous Leishmaniasis in Brazil View
NCT00004754 Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension View
NCT00004753 Long-Term Study of Cerebral Glucose Metabolism in Huntingtons Disease View
NCT00004751 Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia View
NCT00004748 Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis View
NCT00004747 Phase II Randomized Double-Blind Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis View
NCT00004744 Phase III Randomized Double-Blind Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis View
NCT00004740 Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users View
NCT00004739 The Metabolic Effects of Protease Inhibitors in HIV Infected Children View
NCT00004738 Genetic Analysis of the Chiari I Malformation View
NCT00004736 Effectiveness of Anti-HIV Therapy HAART in HIV-Infected Patients With Tuberculosis View
NCT00004735 The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV View
NCT00004734 Vitamin Therapy for Prevention of Stroke View
NCT00004733 Timing of Levodopa Treatment in Parkinsons Disease View
NCT00004732 Carotid Revascularization Endarterectomy Versus Stenting Trial View
NCT00004731 Parkinsons Disease Treatment With Coenzyme Q10 View
NCT00004730 Magnesium Sulfate For Brain Injury View
NCT00004729 Ketogenic Diet for Child Epilepsy and Seizure Control View
NCT00004728 Aspirin Or Warfarin To Prevent Stroke View
NCT00004727 Antiplatelet Therapy to Prevent Stroke in African Americans View
NCT00004705 Study of Uridine Triphosphate UTP as an Aerosol Spray for Cystic Fibrosis View
NCT00004700 Phase II Long Term Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism View
NCT00004699 Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism View
NCT00004697 Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition View
NCT00004696 Study of Morphine in Postoperative Infants to Allow Normal Ventilation View
NCT00004695 Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency View
NCT00004694 Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations View
NCT00004690 Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis View
NCT00004689 Phase II Study of Amithiozone Thiacetazone for Patients With Mycobacterium Avium Complex Pulmonary Disease View
NCT00004688 Phase II Study of Carmustine Streptozocin and Mercaptopurine for Refractory or Recurrent Brain Neoplasms View
NCT00004686 Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis View
NCT00004685 Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy View
NCT00004682 Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis View
NCT00004670 Phase II Study of Pallidotomy for Parkinson Disease View
NCT00004669 Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia View
NCT00004667 Phase I Study of Human Von Willebrand Factor for Von Willebrands Disease View
NCT00004665 Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus View
NCT00004664 Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting View
NCT00004663 Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus View
NCT00004662 Phase III Randomized Double-Blind Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus View
NCT00004661 Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism View
NCT00004660 Randomized Study of Sequential Orbital Radiotherapy for Graves Ophthalmopathy View
NCT00004659 Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors View
NCT00004658 Phase II Study of Ribose Uridine and Thymidine for a Complex Syndrome Involving Excessive 5-Nucleotidase Activity View
NCT00004656 Nutritional Aspects of Rett Syndrome View
NCT00004654 Phase III Randomized Placebo-Controlled Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia View